Home / Dermatologicals / Erythromycin, Combinations
ATC D10AF52 · Antiinfectives for Treatment of Acne · updated 2 Nov 2026
Erythromycin, Combinations shortage
As of 2 Nov 2026, Erythromycin, Combinations has a reported shortage in 1 of the 16 countries we track (Czechia), covering 2 products from 1 company.
Is there an Erythromycin, Combinations shortage?
Yes. As of 2 Nov 2026, Erythromycin, Combinations is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 10 Jan 2028 (Czechia).
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group D10AF · Antiinfectives for Treatment of AcneAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ZINERYT 40MG/ML+12MG/ML 40MG/ML+12MG/ML DRM PLQ SOL 1+1X30ML | CHEPLAPHARM Arzneimittel GmbH, Greifswald | 3 Feb 2026 | 10 Jan 2028 | Manufacturing problem Výrobní důvody |
| CZ | ZINERYT 40MG/ML+12MG/ML 40MG/ML+12MG/ML DRM PLQ SOL 1+1X90ML | CHEPLAPHARM Arzneimittel GmbH, Greifswald | 16 Mar 2026 | 10 Jan 2028 | Manufacturing problem Výrobní důvody |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Erythromycin, Combinations shortage?
Yes. As of 2 Nov 2026, Erythromycin, Combinations is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 10 Jan 2028 (Czechia).
When will Erythromycin, Combinations be back in stock?
Companies expect supply back from 10 Jan 2028 in Czechia; Czechia: 10 Jan 2028. These are company estimates reported to each authority.
Why is Erythromycin, Combinations in short supply?
The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.
Which companies have Erythromycin, Combinations shortages?
Cheplapharm.